Patent ID: 7932228

Claim:
A method for the treatment of bone or prostate cancer comprising the administration to a patient in need of such a treatment a compound of formula I: X-CO-Aaa 0 -Aaa 1 -Aaa 2 -Aaa 3 -Gly-α(Me)Phe-Ser-D-βNal-Aaa 8 -OH (I) or a pharmaceutically acceptable salt or hydrate thereof wherein: X is C n H 2n+1 or C i H 2i —C 6 H 5 , where n is an integer from 1 to 3, and i is an integer from 0 to 3; Aaa 0 is Lys, Orn or Cit; Aaa 1 is Arg or Cit; Aaa 2 is Oic, Hyp or Pro; Aaa 3 is Pro or Oic; and Aaa 8 is Ile, Leu or Nle.